Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2011-03-22
2011-03-22
Foley, Shanon A (Department: 1619)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S237100, C424S456000, C514S703000
Reexamination Certificate
active
07910114
ABSTRACT:
The present invention provides methods of treating a human or other mammal infected with a parasitic microorganism by administering an effective amount in unit dosage form of a C8-C16-alpha, beta-unsaturated aliphatic aldehyde, such as trans-2-dodecenal, to the human or other mammal. The parasitic microorganisms may include trypanosomes, bacteria, fungi and nematodes.
REFERENCES:
patent: 5863775 (1999-01-01), Atkinson et al.
patent: 2004/0214900 (2004-10-01), Forbes et al.
patent: 2005/0014730 (2005-01-01), Carlson et al.
patent: 2007/0160686 (2007-07-01), Augustin et al.
patent: 3325 (2002-09-01), None
Delaquis et al. International Journal of Food Microbiology. 2002; 74: 101-109.
Eyres et al. Journal of Separation Science. 2005; 28: 1061-1074.
Hammer et al. (Journal of Applied Microbiology. 1999; 86: 985-990).
Bisignano et al. (FEMS Microbiology Letters. 2001; 198: 9-13).
Kubo et al. (Journal of Agricultural and Food Chemistry. 2004; 52: 3329-3332).
Janssen et al. (Pharmaceutisch Weekblad Scientific Edition. 1984; 6: 157-160).
Hill et al. (General Poster Session VII, Saturday, Nov. 13, 2004 from the 56th Southeast Regional Meeting 2004 (Nov. 10-13, 2004).
Payne, D. et al., “Antimicrobials The challenge of antibiotic resistant bacterial pathogens: the medical need, the market and prospects for new antimicrobial agents”, Current Opinion in Microbiology, 2004, pp. 435-438, vol. 7.
Moellering, Robert C., Jr., et. al., “Antimicrobial Resistance Prevention Initiative—An Update: Proceedings of an Expert Panel on Resistance”, The American Journal of Medicine, 2007, pp. S4-S25, vol. 120(7).
Dagar, H. S. et al., “Plant Folk Medicines among the Nicobarese of Katchal Island, India”, Economic Botany, 1991, pp. 114-119, vol. 45.
Granzer, Monika et al., “Host-Finding and Host Recognition of InfectiveAncylostoma caninumLarvae”, International Journal for Parasitology, 1991, pp. 429-440, vol. 21(4).
Kopp, Steven R. et al., “High-level pyrantel resistance in the hookwormAncylostoma caninum”, Veterinary Parasitology, 2007, pp. 299-304, vol. 143 (3-4).
Tiwari, J. et al., “Detection of benzimidazole resistance inHaemonchus contortususing RFLP-PCR technique”, Veterinary Parasitology, 2006, pp. 301-307, vol. 138 (3-4).
Gill, Jennifer H. et al., “Detection of Resistance to Ivermectin inHaemonchus contortus”, International Journal for Parasitology, 1991, pp. 771-776, vol, 21(7).
Vickers, M. et al., “Resistance to macrocyclic lactone anthelmintics byHaemonchus contortusandOstertagia circumcinctain sheep in New Zealand”, New Zealand Veterinary Journal, 2001, pp. 101-105, vol. 49(3).
Kaminsky, R. et al., “In vitro assays to determine drug sensitivities of African trypanosomes: a review”, Acta Tropica, 1993, pp. 279-289, vol. 54.
Rifkin, Mary R. et al., “Trypanosome variant surface glycoprotein transfer to target membranes: A model for the pathogenesis of trypanosomiasis”, National Academy of Sciences, 1990, pp. 801-805, vol. 87.
Abenga, J. N. et al., “Implicating roles of animal reservoir hosts in the resurgence of Gambian trypanosomosis (Sleeping Sickness)”, African Journal of Biotechnology, 2005, pp. 134-137, vol. 4(2).
Olila, D. et al., “Bioassay-guided studies on the cytotoxic and in vitro try-panocidal activities of a sesquiterpene ˜˜˜ ( Muzigadial) derived from a Ugandan medicinal plant (Warburgia ugandensis)”, African Health Sciences, 2001, pp. 12-15, vol. 1.
Forbes Wayne M.
Steglich Carolyn
Eckert Seamans Cherin & Mellott , LLC
Foley Shanon A
Marmo, Esq. Carol A.
Slippery Rock University Foundation
LandOfFree
Methods of treating infectious diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treating infectious diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating infectious diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2697129